Ran B Luo1, Toshiaki Suzuki2, Jonathan C Hooker3, Yesenia Covarrubias3, Alexandra Schlein3, Shanglei Liu2, Jeffrey B Schwimmer4,5, Scott B Reeder6, Luke M Funk7, Jacob A Greenberg7, Guilherme M Campos8, Bryan J Sandler2, Santiago Horgan2, Claude B Sirlin3, Garth R Jacobsen2. 1. Division of Minimally Invasive Surgery, Department of Surgery, University of California, San Diego, 9500 Gilman Drive MC 0740, San Diego, CA, 92093, USA. r4luo@ucsd.edu. 2. Division of Minimally Invasive Surgery, Department of Surgery, University of California, San Diego, 9500 Gilman Drive MC 0740, San Diego, CA, 92093, USA. 3. Liver Imaging Group, Department of Radiology, University of California, San Diego, San Diego, CA, USA. 4. Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego, San Diego, CA, USA. 5. Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, CA, USA. 6. Departments of Radiology, Medical Physics, Biomedical Engineering, Medicine and Emergency Medicine, University of Wisconsin, Wisconsin, MI, USA. 7. Department of Surgery, University of Wisconsin, Madison, WI, USA. 8. Division of Bariatric and GI Surgery, Virginia Commonwealth University, Richmond, VA, USA.
Abstract
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is an epidemic in the obese population. Bariatric surgery is known to reverse multiple metabolic complications of obesity such as diabetes, dyslipidemia, and NAFLD, but the timing of liver changes has not been well described. MATERIALS AND METHODS: This was an IRB-approved, two-institutional prospective study. Bariatric patients received MRIs at baseline and after a pre-operative liquid diet. Liver biopsies were performed during surgery and if NAFLD positive, the patients received MRIs at 1, 3, and 6 months. Liver volumes and proton-density fat fraction (PDFF) were calculated from offline MRI images. Primary outcomes were changes in weight, body mass index (BMI), percent excess weight loss (EWL%), liver volume, and PDFF. Resolution of steatosis, as defined as PDFF < 6.4% based on previously published cutoffs, was assessed. Secondarily, outcomes were compared between patients who underwent laparoscopic sleeve gastrectomy (LSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB). RESULTS: From October 2010 to June 2015, 124 patients were recruited. 49 patients (39.5%) completed all five scans. EWL% at 6 months was 55.6 ± 19.0%. BMI decreased from 45.3 ± 5.9 to 34.4 ± 5.1 kg/m2 and mean liver volume decreased from 2464.6 ± 619.4 to 1874.3 ± 387.8 cm3 with a volume change of 21.4 ± 11.4%. PDFF decreased from 16.6 ± 7.8 to 4.4 ± 3.4%. At 6 months, 83.7% patients had resolution of steatosis. Liver volume plateaued at 1 month, but PDFF and BMI continued to decrease. There were no statistically significant differences in liver volume or PDFF reduction from baseline to 6 months between the LSG versus LRYGB subgroups. CONCLUSION: Patients with NAFLD undergoing bariatric surgery can expect significant decreases in liver volume and hepatic steatosis at 6 months, with 83.7% of patients achieving resolution of steatosis. Liver volume reduction plateaus 1-month post-bariatric surgery, but PDFF continues to decrease. LSG and LRYGB did not differ in efficacy for inducing regression of hepatosteatosis.
INTRODUCTION:Nonalcoholic fatty liver disease (NAFLD) is an epidemic in the obese population. Bariatric surgery is known to reverse multiple metabolic complications of obesity such as diabetes, dyslipidemia, and NAFLD, but the timing of liver changes has not been well described. MATERIALS AND METHODS: This was an IRB-approved, two-institutional prospective study. Bariatric patients received MRIs at baseline and after a pre-operative liquid diet. Liver biopsies were performed during surgery and if NAFLD positive, the patients received MRIs at 1, 3, and 6 months. Liver volumes and proton-density fat fraction (PDFF) were calculated from offline MRI images. Primary outcomes were changes in weight, body mass index (BMI), percent excess weight loss (EWL%), liver volume, and PDFF. Resolution of steatosis, as defined as PDFF < 6.4% based on previously published cutoffs, was assessed. Secondarily, outcomes were compared between patients who underwent laparoscopic sleeve gastrectomy (LSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB). RESULTS: From October 2010 to June 2015, 124 patients were recruited. 49 patients (39.5%) completed all five scans. EWL% at 6 months was 55.6 ± 19.0%. BMI decreased from 45.3 ± 5.9 to 34.4 ± 5.1 kg/m2 and mean liver volume decreased from 2464.6 ± 619.4 to 1874.3 ± 387.8 cm3 with a volume change of 21.4 ± 11.4%. PDFF decreased from 16.6 ± 7.8 to 4.4 ± 3.4%. At 6 months, 83.7% patients had resolution of steatosis. Liver volume plateaued at 1 month, but PDFF and BMI continued to decrease. There were no statistically significant differences in liver volume or PDFF reduction from baseline to 6 months between the LSG versus LRYGB subgroups. CONCLUSION:Patients with NAFLD undergoing bariatric surgery can expect significant decreases in liver volume and hepatic steatosis at 6 months, with 83.7% of patients achieving resolution of steatosis. Liver volume reduction plateaus 1-month post-bariatric surgery, but PDFF continues to decrease. LSG and LRYGB did not differ in efficacy for inducing regression of hepatosteatosis.
Authors: David Edholm; Joel Kullberg; Arvo Haenni; F Anders Karlsson; Anders Ahlström; Jakob Hedberg; Håkan Ahlström; Magnus Sundbom Journal: Obes Surg Date: 2011-03 Impact factor: 4.129
Authors: Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin Journal: J Magn Reson Imaging Date: 2011-07-18 Impact factor: 4.813
Authors: An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin Journal: Radiology Date: 2013-02-04 Impact factor: 11.105
Authors: An Tang; Ajinkya Desai; Gavin Hamilton; Tanya Wolfson; Anthony Gamst; Jessica Lam; Lisa Clark; Jonathan Hooker; Tanya Chavez; Brandon D Ang; Michael S Middleton; Michael Peterson; Rohit Loomba; Claude B Sirlin Journal: Radiology Date: 2014-09-22 Impact factor: 11.105
Authors: L Johansson; M Roos; J Kullberg; J Weis; H Ahlström; M Sundbom; B Edén Engström; F A Karlsson Journal: Obes Surg Date: 2008-04-08 Impact factor: 4.129
Authors: Steve C N Hui; Simon K H Wong; Qiyong Ai; David K W Yeung; Enders K W Ng; Winnie C W Chu Journal: Eur Radiol Date: 2018-07-30 Impact factor: 5.315
Authors: Deepa V Cherla; Noe A Rodriguez; Roman Vangoitsenhoven; Tavankit Singh; Neal Mehta; Arthur J McCullough; Stacy A Brethauer; Philip R Schauer; Ali Aminian Journal: Surg Endosc Date: 2019-07-29 Impact factor: 4.584
Authors: Anne Christin Meyer-Gerspach; Ralph Peterli; Michael Moor; Philipp Madörin; Andreas Schötzau; Diana Nabers; Stefan Borgwardt; Christoph Beglinger; Oliver Bieri; Bettina K Wölnerhanssen Journal: Obes Surg Date: 2019-09 Impact factor: 4.129
Authors: Magdalena Eilenberg; Petra Munda; Judith Stift; Felix B Langer; Gerhard Prager; Michael Trauner; Katharina Staufer Journal: Hepatobiliary Surg Nutr Date: 2021-10 Impact factor: 7.293
Authors: Chance S Friesen; Sherwin S Chan; Jonathan B Wagner; Chelsea Hosey-Cojocari; Iván L Csanaky; Valentina Shakhnovich Journal: Clin Transl Sci Date: 2021-01-21 Impact factor: 4.689